 | • レポートコード：MRC2Q12-17979 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、出血性脳卒中用神経血管デバイスのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 出血性脳卒中用神経血管デバイスのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 出血性脳卒中用神経血管デバイスの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 出血性脳卒中用神経血管デバイスのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの出血性脳卒中用神経血管デバイスの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の出血性脳卒中用神経血管デバイスの売上および2028年までの予測に焦点を当てています。 出血性脳卒中用神経血管デバイスのグローバル主要企業には、Stryker Corporation、Medtronic、Johnson & Johnson、Terumo、Abbott Vascular、Acandis、Cerenovus、Ceres Endovascular、Imperative Care、Penumbra、MicroPort Scientific、NICO Corporation、Phenox、Rapid Medical、Shape Memory Medical、Wallaby Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 出血性脳卒中用神経血管デバイス市場は、タイプとアプリケーションによって区分されます。世界の出血性脳卒中用神経血管デバイス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 補助デバイス、神経血栓除去デバイス 【アプリケーション別セグメント】 病院、クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 出血性脳卒中用神経血管デバイス製品概要 - タイプ別市場（補助デバイス、神経血栓除去デバイス） - アプリケーション別市場（病院、クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界の出血性脳卒中用神経血管デバイス販売量予測2017-2028 - 世界の出血性脳卒中用神経血管デバイス売上予測2017-2028 - 出血性脳卒中用神経血管デバイスの地域別販売量 - 出血性脳卒中用神経血管デバイスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別出血性脳卒中用神経血管デバイス販売量 - 主要メーカー別出血性脳卒中用神経血管デバイス売上 - 主要メーカー別出血性脳卒中用神経血管デバイス価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（補助デバイス、神経血栓除去デバイス） - 出血性脳卒中用神経血管デバイスのタイプ別販売量 - 出血性脳卒中用神経血管デバイスのタイプ別売上 - 出血性脳卒中用神経血管デバイスのタイプ別価格 ・アプリケーション別市場規模（病院、クリニック） - 出血性脳卒中用神経血管デバイスのアプリケーション別販売量 - 出血性脳卒中用神経血管デバイスのアプリケーション別売上 - 出血性脳卒中用神経血管デバイスのアプリケーション別価格 ・北米市場 - 北米の出血性脳卒中用神経血管デバイス市場規模（タイプ別、アプリケーション別） - 主要国別の出血性脳卒中用神経血管デバイス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの出血性脳卒中用神経血管デバイス市場規模（タイプ別、アプリケーション別） - 主要国別の出血性脳卒中用神経血管デバイス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の出血性脳卒中用神経血管デバイス市場規模（タイプ別、アプリケーション別） - 主要国別の出血性脳卒中用神経血管デバイス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の出血性脳卒中用神経血管デバイス市場規模（タイプ別、アプリケーション別） - 主要国別の出血性脳卒中用神経血管デバイス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの出血性脳卒中用神経血管デバイス市場規模（タイプ別、アプリケーション別） - 主要国別の出血性脳卒中用神経血管デバイス市場規模（トルコ、サウジアラビア） ・企業情報 Stryker Corporation、Medtronic、Johnson & Johnson、Terumo、Abbott Vascular、Acandis、Cerenovus、Ceres Endovascular、Imperative Care、Penumbra、MicroPort Scientific、NICO Corporation、Phenox、Rapid Medical、Shape Memory Medical、Wallaby Medical ・産業チェーン及び販売チャネル分析 - 出血性脳卒中用神経血管デバイスの産業チェーン分析 - 出血性脳卒中用神経血管デバイスの原材料 - 出血性脳卒中用神経血管デバイスの生産プロセス - 出血性脳卒中用神経血管デバイスの販売及びマーケティング - 出血性脳卒中用神経血管デバイスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 出血性脳卒中用神経血管デバイスの産業動向 - 出血性脳卒中用神経血管デバイスのマーケットドライバー - 出血性脳卒中用神経血管デバイスの課題 - 出血性脳卒中用神経血管デバイスの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Neurovascular Devices for Hemorrhagic Stroke is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Neurovascular Devices for Hemorrhagic Stroke is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Neurovascular Devices for Hemorrhagic Stroke is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Neurovascular Devices for Hemorrhagic Stroke include Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular and Imperative Care, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Neurovascular Devices for Hemorrhagic Stroke manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Neurovascular Devices for Hemorrhagic Stroke market. Further, it explains the major drivers and regional dynamics of the global Neurovascular Devices for Hemorrhagic Stroke market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Stryker Corporation
Medtronic
Johnson & Johnson
Terumo
Abbott Vascular
Acandis
Cerenovus
Ceres Endovascular
Imperative Care
Penumbra
MicroPort Scientific
NICO Corporation
Phenox
Rapid Medical
Shape Memory Medical
Wallaby Medical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Neurovascular Devices for Hemorrhagic Stroke Segment by Type
Support Devices
Neurothrombectomy Devices
Neurovascular Devices for Hemorrhagic Stroke Segment by Application
Hospitals
Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Neurovascular Devices for Hemorrhagic Stroke market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Neurovascular Devices for Hemorrhagic Stroke, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Neurovascular Devices for Hemorrhagic Stroke, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neurovascular Devices for Hemorrhagic Stroke, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurovascular Devices for Hemorrhagic Stroke sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Neurovascular Devices for Hemorrhagic Stroke market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Neurovascular Devices for Hemorrhagic Stroke sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular and Imperative Care, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neurovascular Devices for Hemorrhagic Stroke in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Neurovascular Devices for Hemorrhagic Stroke manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurovascular Devices for Hemorrhagic Stroke sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Neurovascular Devices for Hemorrhagic Stroke Product Introduction
1.2 Market by Type
1.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Support Devices
1.2.3 Neurothrombectomy Devices
1.3 Market by Application
1.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales Estimates and Forecasts 2017-2028
2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Estimates and Forecasts 2017-2028
2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region
2.4.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2017-2022)
2.4.2 Global Sales Neurovascular Devices for Hemorrhagic Stroke by Region (2023-2028)
2.5 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region
2.5.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2017-2022)
2.5.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Manufacturers
3.1.1 Global Top Neurovascular Devices for Hemorrhagic Stroke Manufacturers by Sales (2017-2022)
3.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurovascular Devices for Hemorrhagic Stroke in 2021
3.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Manufacturers
3.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Manufacturers (2017-2022)
3.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neurovascular Devices for Hemorrhagic Stroke Revenue in 2021
3.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurovascular Devices for Hemorrhagic Stroke Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type
4.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Historical Sales by Type (2017-2022)
4.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Forecasted Sales by Type (2023-2028)
4.1.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2028)
4.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type
4.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Historical Revenue by Type (2017-2022)
4.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2017-2028)
4.3 Global Neurovascular Devices for Hemorrhagic Stroke Price by Type
4.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Price by Type (2017-2022)
4.3.2 Global Neurovascular Devices for Hemorrhagic Stroke Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application
5.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Historical Sales by Application (2017-2022)
5.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Forecasted Sales by Application (2023-2028)
5.1.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2028)
5.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application
5.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Historical Revenue by Application (2017-2022)
5.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2017-2028)
5.3 Global Neurovascular Devices for Hemorrhagic Stroke Price by Application
5.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Price by Application (2017-2022)
5.3.2 Global Neurovascular Devices for Hemorrhagic Stroke Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurovascular Devices for Hemorrhagic Stroke Market Size by Type
6.1.1 North America Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2028)
6.1.2 North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2028)
6.2 North America Neurovascular Devices for Hemorrhagic Stroke Market Size by Application
6.2.1 North America Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2028)
6.2.2 North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2028)
6.3 North America Neurovascular Devices for Hemorrhagic Stroke Market Size by Country
6.3.1 North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2028)
6.3.2 North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Neurovascular Devices for Hemorrhagic Stroke Market Size by Type
7.1.1 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2028)
7.1.2 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2028)
7.2 Europe Neurovascular Devices for Hemorrhagic Stroke Market Size by Application
7.2.1 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2028)
7.2.2 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2028)
7.3 Europe Neurovascular Devices for Hemorrhagic Stroke Market Size by Country
7.3.1 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2028)
7.3.2 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Size by Type
8.1.1 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2028)
8.1.2 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2028)
8.2 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Size by Application
8.2.1 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2028)
8.2.2 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2028)
8.3 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Size by Region
8.3.1 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2017-2028)
8.3.2 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Size by Type
9.1.1 Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2028)
9.1.2 Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2028)
9.2 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Size by Application
9.2.1 Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2028)
9.2.2 Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2028)
9.3 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Size by Country
9.3.1 Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2028)
9.3.2 Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Size by Type
10.1.1 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2028)
10.2 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Size by Application
10.2.1 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2028)
10.3 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Size by Country
10.3.1 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Stryker Corporation
11.1.1 Stryker Corporation Corporation Information
11.1.2 Stryker Corporation Overview
11.1.3 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Stryker Corporation Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Terumo
11.4.1 Terumo Corporation Information
11.4.2 Terumo Overview
11.4.3 Terumo Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Terumo Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Terumo Recent Developments
11.5 Abbott Vascular
11.5.1 Abbott Vascular Corporation Information
11.5.2 Abbott Vascular Overview
11.5.3 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Vascular Recent Developments
11.6 Acandis
11.6.1 Acandis Corporation Information
11.6.2 Acandis Overview
11.6.3 Acandis Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Acandis Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Acandis Recent Developments
11.7 Cerenovus
11.7.1 Cerenovus Corporation Information
11.7.2 Cerenovus Overview
11.7.3 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cerenovus Recent Developments
11.8 Ceres Endovascular
11.8.1 Ceres Endovascular Corporation Information
11.8.2 Ceres Endovascular Overview
11.8.3 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ceres Endovascular Recent Developments
11.9 Imperative Care
11.9.1 Imperative Care Corporation Information
11.9.2 Imperative Care Overview
11.9.3 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Imperative Care Recent Developments
11.10 Penumbra
11.10.1 Penumbra Corporation Information
11.10.2 Penumbra Overview
11.10.3 Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Penumbra Recent Developments
11.11 MicroPort Scientific
11.11.1 MicroPort Scientific Corporation Information
11.11.2 MicroPort Scientific Overview
11.11.3 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 MicroPort Scientific Recent Developments
11.12 NICO Corporation
11.12.1 NICO Corporation Corporation Information
11.12.2 NICO Corporation Overview
11.12.3 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 NICO Corporation Recent Developments
11.13 Phenox
11.13.1 Phenox Corporation Information
11.13.2 Phenox Overview
11.13.3 Phenox Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Phenox Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Phenox Recent Developments
11.14 Rapid Medical
11.14.1 Rapid Medical Corporation Information
11.14.2 Rapid Medical Overview
11.14.3 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Rapid Medical Recent Developments
11.15 Shape Memory Medical
11.15.1 Shape Memory Medical Corporation Information
11.15.2 Shape Memory Medical Overview
11.15.3 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shape Memory Medical Recent Developments
11.16 Wallaby Medical
11.16.1 Wallaby Medical Corporation Information
11.16.2 Wallaby Medical Overview
11.16.3 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Wallaby Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurovascular Devices for Hemorrhagic Stroke Industry Chain Analysis
12.2 Neurovascular Devices for Hemorrhagic Stroke Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurovascular Devices for Hemorrhagic Stroke Production Mode & Process
12.4 Neurovascular Devices for Hemorrhagic Stroke Sales and Marketing
12.4.1 Neurovascular Devices for Hemorrhagic Stroke Sales Channels
12.4.2 Neurovascular Devices for Hemorrhagic Stroke Distributors
12.5 Neurovascular Devices for Hemorrhagic Stroke Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurovascular Devices for Hemorrhagic Stroke Industry Trends
13.2 Neurovascular Devices for Hemorrhagic Stroke Market Drivers
13.3 Neurovascular Devices for Hemorrhagic Stroke Market Challenges
13.4 Neurovascular Devices for Hemorrhagic Stroke Market Restraints
14 Key Findings in The Global Neurovascular Devices for Hemorrhagic Stroke Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer